tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NMRA Stock Latest News

Neumora Therapeutics Faces Challenges as It Transitions to Full Public Company Compliance
Company AnnouncementsNeumora Therapeutics Faces Challenges as It Transitions to Full Public Company Compliance
2d ago
NMRA
Neumora Therapeutics’ Earnings Call Highlights Promising Pipeline
PremiumCompany Announcements
Neumora Therapeutics’ Earnings Call Highlights Promising Pipeline
3d ago
NMRA
Neumora Therapeutics, Inc.: Promising Potential in Obesity Therapeutics with NMRA-215
PremiumRatings
Neumora Therapeutics, Inc.: Promising Potential in Obesity Therapeutics with NMRA-215
3d ago
NMRA
Promising Developments and Pipeline Progress Drive Buy Rating for Neumora Therapeutics
PremiumRatings
Promising Developments and Pipeline Progress Drive Buy Rating for Neumora Therapeutics
3d ago
NMRA
Neumora Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Neumora Therapeutics Reports Q2 2025 Financial Results
3d ago
NMRA
Neumora Therapeutics reports Q2 EPS (33c), consensus (37c)
PremiumThe FlyNeumora Therapeutics reports Q2 EPS (33c), consensus (37c)
4d ago
NMRA
Neumora Therapeutics price target raised to $5 from $4 at Mizuho
Premium
The Fly
Neumora Therapeutics price target raised to $5 from $4 at Mizuho
25d ago
NMRA
Neumora Therapeutics’ Promising M4 PAM Program Drives Buy Rating with $18 Price Target
Premium
Ratings
Neumora Therapeutics’ Promising M4 PAM Program Drives Buy Rating with $18 Price Target
1M ago
NMRA
Neumora begins Phase 1 study of NMRA-861
PremiumThe Fly
Neumora begins Phase 1 study of NMRA-861
1M ago
NMRA
Neumora Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Neumora Therapeutics Holds Annual Stockholders Meeting
2M ago
8K
NMRA
Neumora Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
Neumora Therapeutics Faces Nasdaq Non-Compliance Notice
3M ago
8K
NMRA
Neumora Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Neumora Therapeutics’ Earnings Call: Progress Amid Challenges
3M ago
NMRA
Neumora Therapeutics, Inc.: Strengthened Financial Position and Strategic Operational Enhancements Drive Buy Rating
PremiumRatingsNeumora Therapeutics, Inc.: Strengthened Financial Position and Strategic Operational Enhancements Drive Buy Rating
3M ago
NMRA
Strategic Developments and Long-Term Growth Prospects for Neumora Therapeutics Amid Financial Stability Enhancements
Premium
Ratings
Strategic Developments and Long-Term Growth Prospects for Neumora Therapeutics Amid Financial Stability Enhancements
3M ago
NMRA
Neumora Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Neumora Therapeutics Reports Q1 2025 Financial Results
3M ago
NMRA
Neumora Therapeutics reports Q1 EPS (42c), consensus (38c)
PremiumThe Fly
Neumora Therapeutics reports Q1 EPS (42c), consensus (38c)
3M ago
NMRA
Neumora Therapeutics, Inc. (NMRA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Neumora Therapeutics, Inc. (NMRA) Q1 Earnings Cheat Sheet
3M ago
NMRA
Galapagos CEO Paul Stoffels to retire, Henry Gosebruch named CEO of SpinCo
PremiumThe Fly
Galapagos CEO Paul Stoffels to retire, Henry Gosebruch named CEO of SpinCo
4M ago
GLPG
NMRA
Neumora Therapeutics, Inc.: Strategic Advancements and Optimism Drive Buy Rating
PremiumRatings
Neumora Therapeutics, Inc.: Strategic Advancements and Optimism Drive Buy Rating
4M ago
NMRA
Tesla reports deliveries miss, Nintendo says Switch 2 out in June: Morning Buzz
PremiumThe FlyTesla reports deliveries miss, Nintendo says Switch 2 out in June: Morning Buzz
4M ago
BB
UL
Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study
Premium
Ratings
Neumora Therapeutics, Inc. Faces Setbacks with Delayed MDD Program and Discontinued Bipolar Depression Study
4M ago
NMRA
Neumora Therapeutics downgraded to Underperform from Buy at BofA
Premium
The Fly
Neumora Therapeutics downgraded to Underperform from Buy at BofA
4M ago
NMRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >